Abstract
Eosinophilic granulocytes (Eos) represent an inflammatory cell type hypothesized to play a crucial role in the development of chronic asthma (1), after allergen challenge in sensitized animals (2) and atopic subjects (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Frigas, E., G.J. Gleich. 1986. The eosinophil and the pathophysiology of asthma. J. Allergy Clin. Immunol.77: 527–537.
Lellouch-Tubiana, A., J. Lefort, M.-T. Simon, A. Pfister, and B.B. Vargaftig. 1988. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. Am. Rev. Respir. Dis.137: 948–954.
Leiferman, K. M. 1989. Eosinophils in atopic dermatitis. Allergy44: 20–26.
Kay, A.B., H.S. Shin, K.F. Austen. 1973. Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a). Immunology24: 969–976.
Czarnetzki, B.M., W. König, L.M. Lichtenstein. 1976. Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A 23187. J. Immunol.117: 229–234.
Morita, E., J.-M. Schröder, E. Christophers. 1989. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxis. Scand.J.Immunol.29: 709–716.
Wardlaw, A.J., R. Moqbel, O. Cromwell, A.B. Kay. 1986. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest.78: 1701–1712.
Morita, E., J.-M. Schröder, E. Christophers. 1990. Identification of a novel and highly potent eosinophil chemotactic lipid in human eosinophils treated with arachidonic acid. J. Immunol.144: 1893–1900.
Schwenk, U., E. Morita, R. Engel, J.-M. Schröder. 1992. Identification of 5-Oxo-15-hydroxy6,8,11,13-eicosatetraenoic acid as a novel and potent human eosinophil chemotactic eicosanoid. J. Biol. Chem.267: 12482–12488.
Wang, J.M., A. Rambaldi, A. Biondi, Z.G. Chen, C.J. Sanderson, A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol.19: 701–705.
Warringa, R.A.J., L. Koenderman, P.T.M. Kok, J. Kreukmiet, P.L.B. Bruijnzeel. 1991. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony stimulating factor and interleukin3. Blood 77: 2694–2700.
Kameyoshi, Y., E. Morita, J.-M. Schröder, E. Christophers. 1992. Recombinant human interleukin-3 is a chemoattractant for human eosinophils, but not for neutrophils. Submitted for publication.
Rand, T.H., W.W. Cruikshank, D.M. Center, P.F. Weller. 1991. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J. Exp. Med.173: 1521–1528.
Baggiolini, M., A. Walz, S.L. Kunkel. 1989. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest.84: 1045–1049.
Schall TJ. 1991. Biology of the RANTES/SIS cytokine family. Cytokine3: 165–183.
Schröder, J.-M. 1992. Chemotactic cytokines in the epidermis. Exp. Dermatol.1: 12–19.
Schröder, J.-M., U. Mrowietz, E. Morita, E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks Interleukin 1 activity. J. lmmunol.139: 3474–3483.
Yoshimura, T., K. Matsushima, S. Tanaka, E.A. Robinson, E. Appella, JJ. Oppenheim, E.J. Leonard. 1987b. Purification of a human monocyte-derived neutrophil chemotactic factor that shares sequence homology with other host defense cytokines. Proc. Natl. Acad. Sci. USA84: 9233.
Schröder, J.-M., N. Persoon, E. Christophers. 1990. Lipopolysaccharide-stimulated human monocytes secrete apart from NAP-1/11,8 a second neutrophil-activating protein: NHZ terminal aminoacid sequence-identity with melanoma growth stimulatory activity (MGSA/gro). J. Exp. Med.171: 1091–1100.
Moser, B., I. Clark-Lewis, R. Zwahlen, M. Baggiolini. 1990. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J. Exp. Med.171: 1797–1802.
Walz, A., B. Dewald, V. von Tschamer, M. Baggiolini. 1989. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III, and platelet factor 4 on human neutrophils. J. Exp. Med.170: 1745–1750.
Yoshimura, T., N. Yuhki, S.K. Moore, E. Appella, M.I. Lerman, E.J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1): Full-length cDNA cloning, expression in mitogenstimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244: 487–493.
Deuel, T.F., R.M. Senior, D. Chang, D.L. Griffin, R.L. Heinrikson, E.T. Kaiser. 1981. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc. Natl. Acad. Sci. USA78: 4584–4587.
Schröder, J.-M., M. Sticherling, N.-L. M. Perssoon, E. Christophers. 1990. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet factor 4. Biochem. Biophys. Res. Commun.172: 898–904.
Castor, C.W., J.W. Miller, D.A. Walz. 1983. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor. Proc. Natl. Acad. Sci. USA80: 765–769.
Kameyoshi, Y., A. Dörschner, A.I. Mallet, E. Christophers, J.-M. Schröder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med.176: 587–592.
Chignard, M., J.P. Le Conedic, B.B. Vargaftig, J. Benveniste. 1980. Platelet-activating factor (PAF- acether) secretion from platelets: effect of aggregating agents. Br. J. Haematol.46: 455–464.
Schall, Ti., J. Jongstra, Bi. Dyer, J. Jorgensen, C. Claylberger, M.M. Davis, A.M. Krensky. 1988. A human T cell-specific molecule is a member of a new gene family. J. Immunol.141: 1018–1025.
Schall, Ti., K. Bacon, K.J. Toy, D.V. Goeddel. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (Lond.)347: 669–671.
Leiferman, K.M. 1991. A current perspective on the role of eosinophils in dermatologic diseases. J. Am. Acad. Dermatol.24: 1101–1112.
Page, C.P. 1989. Platelets as inflammatory cells. Immunopharmacology17: 51–59.
Coyle, Ai., C.P. Page, L. Atkinson, R. Flanagan, W.J. Metzger. 1990. The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and hieghtened airway responsiveness in allergic rabbits. Am. Rev. Respir. Dis.142: 587–593.
Knauer, K.A., L.M. Lichtenstein, N.F. Adkinson, Jr., and I.F. Fish. 1981. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N. Engl. J. Med.304: 1404–1407.
Gresele, P., S. Grasselli, T. Todisco, and G.G. Nenci. 1985. Platelets and asthma. Lancet, ii: 347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schröder, JM., Kameyoshi, Y., Christophers, E. (1993). Platelets Secrete an Eosinophil-Chemotactic Cytokine which is a Member of the C-C-Chemokine Family. In: Lindley, I.J.D., Westwick, J., Kunkel, S. (eds) The Chemokines. Advances in Experimental Medicine and Biology, vol 351. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2952-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2952-1_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6283-8
Online ISBN: 978-1-4615-2952-1
eBook Packages: Springer Book Archive